| AAPC | Average Annual Percent Change |
| ACOE | Accreditation Council of Oncology in Europe |
| AGENAS | Agenzia Nazionale per i Servizi Sanitari Regionali (Italy’s National Agency for Regional Health Services) |
| AI | Artificial Intelligence |
| APC | Annual Percent Change |
| ARS | Agence Régionale de Santé (France’s Regional Health Agency) |
| AYA | Adolescent and Young Adult (age 15‑39) |
| BRCA | BReast CAncer gene |
| CAR T-cell | Chimeric antigen receptor (CAR)-T cell |
| CCC | Comprehensive cancer centre |
| CI | Confidence interval |
| CME | Continuing medical education |
| CPPs | Cancer Patient Pathways |
| CRC | Colorectal Cancer |
| CT | Computerised tomography |
| CTC | Circulating tumour cells |
| CTIS | Clinical Trials Information System |
| DICA | Dutch Institute for Clinical Auditing |
| DIRAC | International Atomic Energy Agency Directory of Radiotherapy Centres |
| EC | European Commission |
| ECIS | European Cancer Information System |
| EEA | European Economic Area |
| EMA | European Medicines Agency |
| EOC | Early-onset cancer |
| EOL | End-of-life |
| EORTC | European Organisation for Research and Treatment of Cancer |
| ERN GENTURIS | The European Reference Network for patients with one of the rare genetic tumour risk syndromes |
| ESCAT | Scale for Clinical Actionability of molecular Targets |
| ESMO | European Society for Medical Oncology |
| EU | European Union |
| EU+2 | European Union (27 Member States), Iceland and Norway |
| EU11 | 11 EU countries in PaRIS primary healthcare survey |
| EU27 | European Union (27 Member States) |
| EUNetCCC | EU Network of Comprehensive Cancer Centres |
| EuroACT | European Atlas of Clinical Trials in Cancer and Haematology |
| EUROHELICAN | Accelerating gastric cancer reduction in Europe through Helicobacter pylori eradication |
| EU-SILC | European Union Statistics on Income and Living Conditions |
| EUR | Euro |
| EUSOMA | European Society of Breast Cancer Specialists |
| FDA | U.S. Food and Drug Administration |
| FIT | Faecal Immunochemical Test |
| GBD | Global Burden of Disease |
| GDP | Gross domestic product |
| GISTAR | Multicentric randomised study of H. pylori eradication and pepsinogen testing for prevention of gastric cancer mortality |
| GP | General Practitioner |
| gFOBT | Guaiac-based Faecal Occult Blood Test |
| HCQO | Health Care Quality and Outcomes |
| HER2+ | Human epidermal growth factor receptor 2 positive |
| HTA | Health Technology Assessments |
| HPV | Human papillomavirus |
| IAEA | International Atomic Energy Agency |
| IARC | International Agency for Research on Cancer |
| ICBP | International Cancer Benchmarking Partnership |
| ICD‑10 | International Classification of Diseases, 10th revision |
| IHME | Institute for Health Metrics and Evaluation |
| INCa | French National Cancer Institute |
| IT | Information technology |
| LGBTIQ+ | Lesbian, Gay, Bisexual, Transgender, Intersex and Queer |
| LINACs | Linear Accelerators |
| LSI | Linear Accelerator Shortage Index |
| MDTs | Multidisciplinary teams |
| MRI | Magnetic resonance imaging |
| NGS | Next-generation sequencing |
| NRR | National Cancer Registry of Hungary |
| NORDCAN | Association of the Nordic Cancer Registries |
| OECI | Organisation of European Cancer Institutes |
| OOP | Out-of-Pocket |
| P3CEQ | Person-Centred Co‑ordinated Care Experiences Questionnaire |
| PaRIS | Patient-Reported Indicators Survey |
| PARP inhibitors | Medicines that inhibit the enzyme poly ADP ribose polymerase (PARP) |
| PET | Positron Emission Tomography |
| PHC | Primary Health Care |
| PFOA | Perfluorooctanoic Acid |
| PNE | Programma Nazionale Esiti (Italy’s National Outcomes Evaluation Programme) |
| p.p. | Percentage points |
| PRAISE‑U | PRostate cancer Awareness and Initiative for Screening in the European Union |
| PREMs | Patient-Reported Experience Measures |
| PROMIS | Patient-Reported Outcomes Measurement Information System |
| PROMs | Patient-Reported Outcomes Measures |
| PRS | Polygenic risk score |
| PSA | Prostate‑specific antigen |
| QALY | Quality-adjusted life year |
| RDC(s) | Rapid Diagnostic Centre(s) |
| SCPs | Survivorship care plans |
| SEER | Surveillance, Epidemiology, and End Results (United States) |
| SES | Socio-economic Status |
| SHARE | Survey on Health, Ageing and Retirement in Europe |
| SOLACE | Strengthening the screening of Lung Cancer in Europe |
| TNF inhibitors | Medicines that inhibit tumour necrosis factor |
| TNM | Tumour, Node, Metastasis |
| TOGAS | Towards gastric cancer screening implementation in the European Union |
| UEMS | The European Union of Medical Specialists |
| USD | United States dollar |
| USPSTF | United States Preventive Services Task Force |
| UV | Ultraviolet |
Delivering High Value Cancer Care
European Cancer Inequalities Registry Analytical Report
